Nm23-H1 can induce cell cycle arrest and apoptosis in B cells.
Nm23-H1 is a well-known tumor metastasis suppressor, which functions as a nucleoside-diphosphate kinase converting nucleoside diphosphates to nucleoside triphosphates with an expense of ATP. It regulates a variety of cellular activities, including proliferation, development, migration and differentiation known to be modulated by a series of complex signaling pathway. Few studies have addressed the mechanistic action of Nm23-H1 in the context of these cellular processes. To determine the downstream pathways modulated by Nm23-H1, we expressed Nm23-H1 in a Burkitt lymphoma derived B-cell line BJAB and performed pathway specific microarray analysis. The genes with significant changes in expression patterns were clustered in groups which are responsible for regulating cell cycle, p53 activities and apoptosis. We found a general reduction of cell cycle regulatory proteins including cyclins and cyclin dependent kinase inhibitors (anti proliferation), and upregulation of apoptotic genes which included caspase 3, 9 and Bcl-x. Nm23-H1 was also found to upregulate p53 and downregulate p21 expression. A number of these genes were validated by real time PCR and results from promoter assays indicated that Nm23-H1 expression downregulated cyclin D1 in a dose responsive manner. Further, we show that Nm23-H1 forms a complex with the cellular transcription factor AP1 to modulate cyclin D1 expression levels. BJAB cells expressing Nm23-H1 showed reduced proliferation rate and were susceptible to increased apoptosis which may in part be due to a direct interaction between Nm23-H1 and p53. These results suggest that Nm23-H1 may have a role in the regulation of cell cycle and apoptosis in human B-cells.
Choudhuri
Tathagata
T
Division of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.
Murakami
Masanao
M
Kaul
Rajeev
R
Sahu
Sushil K
SK
Mohanty
Suchitra
S
Verma
Subhash C
SC
Kumar
Pankaj
P
Robertson
Erle S
ES
D017209:Apoptosis / Q000235:genetics*; D001402:B-Lymphocytes; D002051:Burkitt Lymphoma; D002453:Cell Cycle / Q000235:genetics*; D002454:Cell Differentiation / Q000235:genetics; D045744:Cell Line, Tumor; D015536:Down-Regulation; D020869:Gene Expression Profiling; D016158:Genes, p53; D006801:Humans; D054778:NM23 Nucleoside Diphosphate Kinases / Q000235:genetics* / Q000502:physiology; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D015854:Up-Regulation
D054778:NM23 Nucleoside Diphosphate Kinases; C517938:NME1 protein, human
Nucleic Acids Res. 2002 Dec 15;30(24):5465-75
12490715
Taiwan J Obstet Gynecol. 2006 Jun;45(2):107-13
17197349
J Biol Chem. 2002 Jan 11;277(2):1560-7
11694515
Biochem Biophys Res Commun. 2001 Dec 7;289(3):738-43
11726210
J Natl Cancer Inst. 1994 Dec 21;86(24):1838-44
7990158
Virology. 2006 Jul 20;351(1):58-72
16631833
J Natl Cancer Inst. 2005 Jun 1;97(11):836-45
15928304
Cell Death Differ. 2001 May;8(5):470-6
11423907
Int J Cancer. 2004 Mar;109(1):65-70
14735469
Oncogene. 1993 Sep;8(9):2325-33
8395676
Cell. 2003 Mar 7;112(5):659-72
12628186
Cancer Res. 1988 Nov 15;48(22):6550-4
2460224
J Biol Chem. 1996 Oct 11;271(41):25107-16
8810265
J Bioenerg Biomembr. 2000 Jun;32(3):247-58
11768308
Science. 2001 Apr 27;292(5517):727-30
11326099
J Virol. 2006 Apr;80(7):3445-58
16537612
Biochem Biophys Res Commun. 1998 Feb 13;243(2):342-8
9480811
Biochem Biophys Res Commun. 2009 Sep 4;386(4):607-11
19540190
J Virol. 2005 Aug;79(15):9714-24
16014933
J Virol. 2007 Jun;81(12):6718-30
17409144
Biochem Biophys Res Commun. 2004 Aug 6;320(4):1063-8
15249197
J Virol. 2006 Jul;80(13):6411-9
16775329
Cell Growth Differ. 1996 Dec;7(12):1689-95
8959337
Acta Pharmacol Sin. 2008 Dec;29(12):1451-8
19026164
Cancer Res. 2003 Sep 1;63(17):5454-61
14500381
Breast Cancer Res Treat. 1993;25(2):175-87
8347849
Mol Carcinog. 2006 Aug;45(8):627-33
16739125
J Virol. 2006 Feb;80(3):1321-31
16415009
FEBS Lett. 2002 Feb 13;512(1-3):334-40
11852106
Oncogene. 1997 Feb 20;14(7):837-47
9047391
J Biol Chem. 1997 Feb 28;272(9):5525-32
9038158
Mol Carcinog. 2003 Apr;36(4):204-14
12669312
Cancer Res. 2007 Aug 1;67(15):7238-46
17671192
Virology. 2006 Aug 1;351(2):393-403
16701788
Virology. 2009 Jun 5;388(2):236-47
19394062
Int J Cancer. 2008 Aug 1;123(3):500-10
18470881
Am J Pathol. 2005 Sep;167(3):869-77
16127164
Cell Growth Differ. 1992 Dec;3(12):873-9
1472467
Nature. 1989 Nov 9;342(6246):177-80
2509941
Vestn Oftalmol. 2001 Mar-Apr;117(2):27-9
11510160
J Bioenerg Biomembr. 2006 Aug;38(3-4):215-25
17103045
J Biol Chem. 2002 Jun 7;277(23):20895-902
11919189
Virology. 1979 Apr 30;94(2):460-9
452423
Exp Cell Res. 2000 Nov 25;261(1):127-38
11082283
Int J Cancer. 1997 Oct 9;73(2):297-302
9335458
Mol Cell Biol. 2005 Feb;25(4):1379-88
15684389
Cancer Cell. 2004 Feb;5(2):137-49
14998490
J Virol. 2009 May;83(10):4871-83
19116252
J Biol Chem. 2007 Nov 30;282(48):35293-307
17916563
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9
2823272
J Biol Chem. 1998 Jan 2;273(1):1-4
9417035
Comp Biochem Physiol B. 1973 Jun 15;45(2):355-64
4351428
PLoS One. 2009 Nov 23;4(11):e7949
19956735
BMC Mol Biol. 2007 Dec 20;8:113
18093344
Cancer Res. 2007 Dec 15;67(24):11751-9
18089805
Cancer Biol Ther. 2003 Mar-Apr;2(2):196-202
12750563
Cell Cycle. 2008 Sep 15;7(18):2856-67
18769160
J Virol. 2007 Oct;81(19):10352-61
17634231
J Biol Chem. 2005 May 20;280(20):20059-68
15738001